Characteristics | N (%) |
---|---|
DENV serotypes | Â |
Mono-infection | 222 (84.7) |
 DENV-1 | 170 (76.6) |
 DENV-2 | 44 (19.8) |
 DENV-3 | 7 (3.2) |
 DENV-4 | 1 (0.5) |
Co-infection | 40 (15.3) |
 DENV-1/DENV-2 | 34 (85) |
 DENV-1/DENV-3 | 5 (12.5) |
 DENV-2/DENV-3 | 1 (2.5) |
Race | Â |
 Malay | 157 (59.9) |
 Chinese | 34 (13) |
 Indian | 29 (11.1) |
 Foreign workers | 37 (14.1) |
 Others | 5 (1.9) |
 Male | 146 (55.7) |
Age groups | Â |
 <18 | 38 (14.5) |
 18-29 | 104 (39.7) |
 30-39 | 64 (24.4) |
 40-49 | 27 (10.3) |
 50-59 | 17 (6.5) |
 >60 | 12 (4.6) |
 Pregnancy | 14 (5.3) |
Comorbiditiesa | 52 (19.8) |
 Diabetes mellitus | 21 (8) |
 Hypertension | 15 (5.7) |
 Asthma | 14 (5.3) |
 Cardiovascular disease | 6 (2.3) |
 Blood disorderb | 4 (1.5) |
 Malignancyc | 4 (1.5) |
 Psychiatric disorders | 4 (1.5) |
 Othersd | 5 (1.9) |